Sponsors

Panel for interfering substances

Firefly Scientific has launched its OptiChallenge Inhibition Panel for use in evaluating the performance of an assay in the presence of interfering substances.

The sevenmember panel is the very first to provide quantified amounts of commonly recognised inhibitors. The panel members represent elevated levels of inhibitory substances encountered routinely in the normal patient population.

Interfering substances such as heparin, lipids, bilirubin and haemolysed plasma are found commonly in patient samples. At minimal levels, these substances do not interfere with assay results. However, when levels become elevated due to the effect of lifestyle or medications, these substances can hinder the amplification of nucleic acid assays. Studies show that 12.5% of incorrect and delayed test results affect patient health.

The OptiChallenge Inhibition Panel allows laboratories to identify limitations in testing due to the presence of interfering substances and enables appropriate actions to be taken.

www.fireflyscientific.co.uk

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026